KA

Kari Alitalo

LR Ludwig Institute For Cancer Research: 7 patents #1 of 94Top 2%
LL Licentia Group Limited: 4 patents #1 of 23Top 5%
HL Helsinki University Licensing: 2 patents #1 of 8Top 15%
AS Aventis Pharma S.A.: 1 patents #26 of 104Top 25%
UP University Of Pittsburgh: 1 patents #4 of 25Top 20%
📍 Helsinki, FI: #2 of 246 inventorsTop 1%
Overall (2004): #3,893 of 270,089Top 2%
7
Patents 2004

Issued Patents 2004

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
6824777 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy Arja Kaipainen, Reija Valtola, Lotta Jussila 2004-11-30
6818220 Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof Vladimir Joukov 2004-11-16
6793918 In vivo stimulation of angiogenic activity Berndt Enholm, Didier Branellec, Seppo Ylae-Herttuala, Ralf Pettersson, Erika Bergsten +2 more 2004-09-21
6764820 Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3) Robert Ferrell, David N. Finegold, Marika Karkkainen 2004-07-20
6730658 Stimulation of lymphatic growth with an FLT4 ligand Vladimir Joukov 2004-05-04
6706687 Platelet-derived growth factor D Ulf Eriksson, Karin Aase, Xuri Lee, Annica Ponten, Marko Uutela +2 more 2004-03-16
6689580 Growth factor Marc G. Achen, Andrew Frederick Wilks, Steven Stacker 2004-02-10